Victoria J Findlay discovered that SNAI2 regulated CRC 5-fluorouracil sensibility through inhibiting miR145, and proposed that the SNAI2/miR145 pathway may be a response predictor and new clinical therapeutic target in CRC chemotherapy (42). The gene discussed is SNAI2; the disease is colorectal carcinoma.